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Abstract
We previously found that a directional movement of the raft component GD3 towards mitochondria, by its association with
microtubules, was mandatory to late apoptogenic events triggered by CD95/Fas. Since CLIPR-59, CLIP-170-related protein,
has recently been identified as a microtubule binding protein associated with lipid rafts, we analyzed the role of GD3-CLIPR-
59 association in lymphoblastoid T cell apoptosis triggered by CD95/Fas. To test whether CLIPR-59 could play a role at the
raft-microtubule junction, we performed a series of experiments by using immunoelectron microscopy, static or flow
cytometry and biochemical analyses. We first assessed the presence of CLIPR-59 molecule in lymphoblastoid T cells (CEM).
Then, we demonstrated that GD3-microtubule interaction occurs via CLIPR-59 and takes place at early time points after
CD95/Fas ligation, preceding the association GD3-tubulin. GD3-CLIPR-59 association was demonstrated by fluorescence
resonance energy transfer (FRET) analysis. The key role of CLIPR-59 in this dynamic process was clarified by the observation
that silencing CLIPR-59 by siRNA affected the kinetics of GD3-tubulin association, spreading of GD3 towards mitochondria
and apoptosis execution. We find that CLIPR-59 may act as a typical chaperone, allowing a prompt interaction between
tubulin and the raft component GD3 during cell apoptosis triggered by CD95/Fas. On the basis of the suggested role of lipid
rafts in conveying pro-apoptotic signals these results disclose new perspectives in the understanding of the mechanisms by
which raft-mediated pro-apoptotic signals can directionally reach their target, i.e. the mitochondria, and trigger apoptosis
execution.
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Introduction
Cytoplasmic linker proteins (CLIPs),microtubule-binding proteins,
are involved in intracellular organization and organelle movement
[1]. In particular, several CLIP-170-related proteins, characterized
by the presence of a cytoskeleton-associated protein-Gly motif that
interacts with tubulin, are active at the organelle-microtubule
interface [2]. Recently, CLIPR-59, a new CLIP-170-related protein,
has been identified [3], which is involved in the regulation of
microtubule dynamics. In addition to its microtubule binding,
CLIPR-59 can also be associated with glycosphingolipid enriched
microdomains on cell plasma membrane, i.e. with the so-called lipid
rafts [4]. It has been proposed that this raft-associated CLIP could
play a role at the raft-microtubule junction [4] and in the regulation
of membrane trafficking [3]. Moreover, recent evidence showed that
CLIPR-59functionsas ascaffoldproteinthatinteractswithphospho-
Akt and regulates Akt cellular compartmentalization [5]. The role of
CLIPR-59 in the regulation of signal transduction pathway(s) is
related to its association with lipid rafts on the cell surface. Indeed, the
last 30 amino acids of CLIPR-59 are required to target it to the
plasma membrane and a double palmitoylation on tandem cysteines
within this domain is responsible for the raft targeting.
Lipid rafts have been associated with several cell functions [6,7],
including cell death. It has in fact been suggested that lipid rafts
could play a key role in receptor-mediated apoptosis of T cells
[8,9]. This is apparently due to two events that follow the receptor
engagement: i) the recruitment of CD95/Fas [9–11] as well as
other Tumor Necrosis Factor-family receptors [12] to plasma
membrane lipid rafts, and ii) the recruitment of specific
proapoptotic bcl-2 family proteins to mitochondrial ‘‘raft-like
microdomains’’ [13]. Indeed, small lipid domains are also present
on mitochondrial membrane, where they may contribute to
apoptosis-associated modifications of the organelle, i.e. its
remodeling and fission, as well as to the release of apoptogenic
factors and apoptosis execution [10,13]. These raft-like micro-
domains are enriched in gangliosides (GD3, GM3) and cardiolipin
[14], but show a relatively low content of cholesterol; some
molecules, including the voltage-dependent anion channel-1 and
the fission protein hFis1, are enriched, whereas Bcl-2 family
proteins (truncated Bid and Bax) are recruited, following CD95/
Fas triggering [13]. Both mitochondria depolarization and
cytochrome c release are dependent on raft-like microdomain
integrity, since the disruption of raft-like microdomains by methyl-
b-cyclodextrin prevented mitochondria depolarization or cyto-
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Bid) [13]. We recently identified microtubular network as pivotal
in the intracellular directional redistribution of lipid raft
components [15]. We showed the association of GD3 with alpha
and beta tubulin. In particular, in silico docking analysis showed
that GD3 has a high affinity for the pore formed by four tubulin
heterodimers (type I pore), thus suggesting a possible interaction
between tubulin and GD3. Hence, microtubules could act as
tracks for ganglioside redistribution following apoptotic stimula-
tion, possibly contributing to the mitochondrial alterations leading
to cell death.
The present study was thus undertaken to ascertain whether the
movement of GD3 from the plasma membrane towards the
mitochondrion via microtubules could be instructed by its
association with CLIPR-59. In fact, we found that this small
molecule seems to behave as a typical chaperone allowing a
prompt interaction between tubulin and ganglioside GD3, here
considered as a paradigmatic microdomain component [10]
regulating CD95/Fas-triggered apoptosis in lymphoblastoid T
cells (CEM).
Results
Analysis of CLIPR-59 distribution in CEM cells
CLIPR-59, a CLIP-170-related protein, has recently been
identified as a microtubule binding protein associated with lipid
rafts [4]. To test whether raft-associated CLIPR-59 could play a
role at the raft-microtubule junction, we performed a series of
experiments by using immunoelectron microscopy, static and flow
cytometry as well as biochemical analyses. We first assessed the
presence of CLIPR-59 molecule in CEM cells. Studies on CLIPR-
59 association to lipid rafts and microtubules were indeed
previously conducted in CLIPR-59-transfected cells only [3,4].
In CEM cells we found a small, but well-defined, presence of
CLIPR-59 gold labeling at the cell surface, (Fig. 1A, note the
absence of any sign of non-specific labeling). Interestingly, after
CD95/Fas triggering, CLIPR-59 was detectable on microtubules
(Fig. 1B, arrows indicate 10 nm gold particles). Positivity for
CLIPR-59 was also confirmed by flow cytometry analyses
(Fig. 1C–D). Western blot analysis of CLIPR-59, either in the
presence or in the absence of CD95 stimulation, revealed that
CLIPR-59 expression was substantially unchanged, supporting the
view that apoptosis triggering does not change CLIPR-59
expression, but affects its redistribution from plasma membrane
domains to microtubules (Fig. 1E).
Analysis of CLIPR-59 association with GD3
To assess the possible implications of the association CLIPR-
59/GD3 for GD3 trafficking, specific experiments were then
carried out. Static cytometry analyses performed at different time
points indicated that a co-localization of GD3 with CLIPR-59 was
detectable 15 minutes after Fas-triggering (Fig. 2A). Parallel
FRET analyses indicated that GD3/CLIPR-59 association was
evident 15 minutes after anti-CD95/Fas administration, reaching
a peak after 30 minutes (Fig. 2B, representative experiment). Of
note, CD95/Fas treatment virtually did not modify the expression
of CLIPR-59 (Fig. 2B, insets). However, the results obtained by
FRET analyses also underline that the association CLIPR-59/
GD3 occurred earlier than the association GD3/b-Tubulin, as
shown by the slight shift of the two association curves based on
values obtained by FRET analyses (Fig. 2C and Fig. S1). In
addition, to test the role of cysteine palmitoylation of CLIPR59 in
the GD3 traffic, parallel experiments were performed by
pretreating cells with 100 mM 2-Bromopalmitate to inhibit
palmitoylation. The analysis revealed that pretreatment signifi-
cantly prevented GD3/CLIPR59 interaction, as revealed by
FRET analysis (Fig. 3A and B).
Figure 1. GD3 associates with CLIPR-59 after anti-CD95/Fas
apoptotic triggering. Immunoelectron microscopy analysis of CLIPR-
59 distribution by immunogold staining using post-embedding
technique clearly indicated a surface staining in control CEM cells (A)
and a microtubule associated gold labeling in anti-CD95/Fas treated
cells (B). Arrows indicate gold particles. Note the absence of non-
specific labeling. (C) Flow cytometric analysis of CLIPR-59 expression in
control CEM cells; (D) Flow cytometric analysis of CLIPR-59 expression in
anti-CD95/Fas treated cells. (E) Western Blot analysis of CLIPR-59
expression in control or in anti-CD95/Fas treated cells. As a loading
control b-actin is shown.
doi:10.1371/journal.pone.0008567.g001
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PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8567Figure 2. Static and flow cytometric analyses of GD3/CLIPR-59 association. (A) Immunofluorescence analysis after double staining of
GD3 (red) and CLIPR-59 (green) in untreated CEM cells and after treatment with anti-CD95/Fas (only merge pictures are shown). Note GD3/
CLIPR-59 co-localization (yellow staining) at different time points (starting from 15 min) and the absence of any co-localization 90 min after anti-
CD95/Fas treatment (bottom panel). (B) Quantitative evaluation of GD3/CLIPR-59 association by FRET technique, as revealed by flow cytometry
analysis. This association was negligible in untreated CEM cells, started after 15 min after anti-CD95/Fas administration, reached its peak 30 min
later and dropped down 90 min after treatment. Numbers represent the FRET efficiency indicating the GD3/CLIPR-59 association. Results
obtained in one experiment representative of four are shown. Inset: flow cytometry analysis of CLIPR-59 expression at different times of anti-
CD95/Fas treatment. (C) Time course analysis of the association GD3/CLIPR-59 compared with GD3/b-Tubulin association in CEM cells after anti-
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and apoptosis
In order to demonstrate the role of CLIPR-59 as a regulator of
GD3 trafficking, a small interfering RNA (siRNA) was employed to
ablate CLIPR-59 and its function. Western blot analyses of siRNA-
treated cells revealed that CLIPR-59 expression appeared to be
significantly reduced as compared to control cells (Fig. 4A), as
Figure 3. Effect of 2-Bromopalmitate on GD3/CLIPR-59 associ-
ation. Quantitative evaluation of GD3/CLIPR-59 association by FRET
technique, as revealed by flow cytometry analysis. This association,
negligible in untreated cells, started 15 min after the administration of
anti-CD95/Fas (250 ng/ml for different incubation times at 37uC)
reached its peak 30 min later and dropped down 90 min after
treatment (left column). In cell pre-treated with 100 mM 2-Bromopalmi-
tate for 3 h at 37uC to inhibit palmitoylation, GD3/CLIP-59 association
was inhibited at any time (right column). Numbers represent the
percentage of FL3 positive cells indicating the GD3/CLIPR-59 associa-
tion. Results obtained in one experiment representative of three are
shown. (B) Time course analysis of the association GD3/CLIPR-59
obtained pooling together results of three independent experiments.
Data are reported as mean values6SD.
doi:10.1371/journal.pone.0008567.g003
Figure 4. Analysis of CLIPR-59 expression and transfection
efficiency. A) CEM cells, transfected or not with 100 nM smart pool
siRNA targeting CLIPR-59, were lysed, resolved by SDS-PAGE and
transferred to nitrocellulose. Samples were probed with anti-CLIPR-59
polyclonal antibodies or with anti-b-actin as a control. The immuno-
reactivity was assessed by chemiluminescence reaction using the ECL
western blocking detection system. B) Densitometric scanning analysis
of the CLIPR-59 expression was performed by MAC OS 9.0, using NIH
image 1.62 software. C) CEM cells, transfected or not with 100 nM siGLO
laminin A/C siRNA, were fixed with 2% paraformaldehyde and the
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efficiency, confirmed by positive control siGLO laminin A/C
siRNA with fluorescent label, was about 60% (Fig. 4C).
The analysis of GD3/b-tubulin association was thus carried out
by FRET technique at different time points (15–90 minutes) after
CD95/Fas administration. The results obtained in a representative
experiment are reported in Figure 5A and B. The data show that
silencing of CLIPR-59 by siRNA affected the kinetics of GD3-b-
tubulin association, after CD95/Fas administration. Indeed, the
maximum FRET efficiency (FE) was detected 30 minutes after anti-
CD95/Fas triggering in control non-silenced cells (Fig. 5A)
(FE:1.3211 vs 0.2385 in CLIPR-59 siRNA treated cells), whereas
in CLIPR-59 siRNA treated cells similar FRET efficiency values
(FE: 1.1094) were detected only after 75 minutes (Fig. 5B). Notably,
at this time point, GD3/b-tubulin association was negligible in
control samples (FE: 0.2160). This delay was better appreciable by
pooling together the results obtained from three different experi-
ments(Fig.5C,wherethe GD3/b-tubulinassociationisreportedas
a function of time). In fact, ANOVA two-way for repeated measures
showed a not significant effect of treatment (F 1,48=3.60,
P=0.0942), but a significant time (F 6,48=188.89, P,0.0001)
and treatment x time interaction (F 6,48=225.53; P,0.0001). This
indicates that the two curves have a similar trend but also that a
significant ‘‘delay’’ of GD3/b-Tubulin association is induced by
CLIPR-59 siRNA treatment (see Fig. S2A–C). Similarly,
immunofluorescence analysis after double staining of GD3 (red)
and mitochondria (green) in control and CLIPR-59 siRNA treated
cells revealed different kinetics of GD3/mitochondria association,
after treatment with anti-CD95/Fas. Indeed, GD3/mitochondria
colocalization was detected 30 minutes after anti-CD95/Fas
triggering in control cells, but was impaired in CLIPR-59 siRNA
treated cells (Fig. 5D). As a control, parallel staining was performed
withR24anti-GD3 monoclonal antibody(MoAb), which revealed a
similar distribution pattern (Fig. S3). Further analyses were also
conducted to evaluate apoptotic rates at different time points up to
180 min. The analysisof the hypodiploidpeakrevealed a significant
delay of CD95/Fas triggered apoptosis in siRNA treated cells as
compared to non-silenced cells (Fig. 5E).
Discussion
The present work deals with the trafficking of glycosphingolipid
GD3 to the mitochondrion upon pro-apoptotic triggering induced
by CD95/Fas ligation and identifies the pivotal role of
microtubule-associated protein CLIPR-59 in instructing and
regulating GD3-microtubule association.
The re-distribution of GD3 in lymphoblastoid T cells may play a
decisive role in the apoptosis cascade. Previous works, including
ours, identified the mitochondria as possible targets for GD3 and
hypothesized that the rearrangement of GD3 may be involved in
the mitochondrial remodeling leading to apoptosis execution phase
[13,16,17]. It was in fact suggested that mitochondria remodeling in
terms of structural modifications, i.e. their curvature changes, as
well as their fission process, could be under the influence of several
molecules, including lipid microdomains. It was also proposed that
it could play a key role in late apoptotic mitochondria-mediated
events, i.e. the release form this organelle of apoptogenic factors
such as cytochrome c [13,18,19]. In this scenario we hypothesized
that lipid rafts constituents (GD3), normally localized mainly at the
cell surface [20] and able to engulf a series of molecules of
importance in the cell suicide process [9,11,12], can proceed from
the cell plasma membrane (and/or from trans Golgi network) to the
mitochondria via a microtubule-dependent mechanism. Microtu-
bules may be used as tracks to direct intracytoplasmic transport of
lipid raft glycosphingolipid(s) to mitochondria. This was demon-
strated by the observed association of GD3 with tubulin and by the
experiments previously carried out by inhibiting microtubule
polymerization [15]. Under these experimental conditions, the
trafficking of GD3 molecule towards mitochondria appeared to be
impaired. However, the fact that the integrity of microtubules is
mandatory for GD3 association to tubulin is still puzzling. This
question remains to be elucidated and some insight may come from
the studies carried out in this paper in which we analyzed the
microtubule associated protein CLIPR-59. In fact, CLIPR-59, in
addition to its microtubule binding, has recently been shown to be
associated with lipid rafts by a double palmitoylation on tandem
cysteines within the C-terminal domain [4].
Since CLIPR-59 is associated not only with the plasma
membrane, but is also targeted to trans Golgi network membranes,
it may regulate both plasma membrane and trans Golgi network
interactions via microtubules. Here, in addition, we demonstrated,
by FRET, that CLIPR-59 is also capable of directly interacting
with lipid raft-associated GD3. Interestingly, it was proposed that
CLIPR-59 binds microtubules only when already localized to its
membrane target [3]. It can therefore be hypothesized that it can
play a role either as cytoplasmic linker between lipid rafts and
microtubules or to locally destabilize the assembly of microtubules
close to lipid rafts [4]. More in general, according to CLIP model
[1], CLIPR-59 would establish an interaction between cell
membranes and microtubules, thus regulating membrane dynam-
ics. In particular, CLIPR-59 may facilitate rafts/microtubules
interaction following anti-CD95/Fas treatment. This model would
explain the shift observed between association kinetics of GD3 to
CLIPR-59 and b-Tubulin, as revealed by FRET analyses. Our
results support the view that CLIPR-59 is involved in intracellular
trafficking, acting as a chaperone molecule allowing a fast and
prompt interaction between GD3 and tubulin, once apoptosis has
been triggered by CD95/Fas. In particular, findings of the
experiments with 2-Bromopalmitate suggest that palmitoylation of
CLIPR59 plays a key role in the overall process of GD3/tubulin
interaction. Moreover, the key role of CLIPR-59 in this dynamic
process is clarified by the observation that silencing CLIPR-59 by
siRNA resulted in a delayed GD3-b-tubulin association and,
consequently, a delayed apoptosis execution, probably via an
inhibited spreading of GD3 towards mitochondria. However, we
cannot exclude the possibility that other, still unidentified,
molecules may drive GD3 traffic. In particular, we demonstrated
that ezrin, a cytoskeletal protein, may directly interact with GD3
in uropods of lymphoblastoid CEM cells during cell apoptosis
triggered by CD95/Fas [21]. Furthermore, on the basis of
literature [22] and according to [5], we can hypothesize that the
interaction of CLIPR-59 with Akt could play a role in the cascade
of events leading to the observed significant delay of apoptotic
execution. In fact, since Akt activation is known to inhibit
apoptosis, we cannot rule out the possibility that affecting
CLIPR59 function could impair signaling through lipid rafts,
which results in Akt inactivation and cell death.
Taken together, our findings bolster the role played by lipid rafts
in the apoptotic program and their role in the preparatory
homework for cell suicide apoptosis introducing a new actor in the




CEM cells obtained from a human acute lymphoblastic
leukemia were cultured as described [23]. Apoptosis was induced
GD3-CLIPR-59 Association
PLoS ONE | www.plosone.org 5 January 2010 | Volume 5 | Issue 1 | e8567Figure 5. Effect of CLIPR-59 siRNA on GD3/b-Tubulin association and apoptosis. (A–B) Time-course cytometric analysis of GD3/b-Tubulin
association byFRETtechnique in control non-silencedcells (A) and in CLIPR-59 siRNA treated cells (B).Numbers representthe percentage of cells in which
GD3/b-Tubulin association occurred. Results obtained in one experiment representative of three are shown. Note that FRET from acceptor to donor
(indicating molecular association): i) reached its peak 30 min after anti-CD95/Fas administration in control cells and 75 min after CD95/Fas triggering in
CLIPR-59 silenced cells and ii) dropped down 60 min after anti-CD95/Fas treatment in control cells and 90 min in CLIPR-59 siRNA treated cells. (C)
Comparative time course analysis of GD3/b2T ubulin association (by FRET analysis) in control and CLIPR-59 siRNA treated cells. (D) Immunofluorescence
analysis after double staining of GD3 (red) and mitochondria (green) in control and CLIPR-59 siRNA treated cells 30 and 75 min after treatment with anti-
CD95/Fas (only merge pictures are shown). Note that GD3/mitochondria co-localization (yellow staining) was detectable at different time points after
CD95/Fas treatment. (E) Comparative time course analysis of apoptosis (by evaluating the hypodiploid peak). Results are reported as mean values from
three independent experiments6SD. Note the ‘‘delay’’ of both apoptosis and GD3/b-tubulin association induced by CLIPR-59 silencing by siRNA.
doi:10.1371/journal.pone.0008567.g005
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5 per ml in complete
medium by adding anti-Fas (CD95) IgM MoAb (clone CH11,
Upstate Biotechnology, Lake Placid, NY USA) at 250 ng/ml for
different incubation times.
Detection of CLIPR-59 by transmission electron
microscopy
CEM cells, untreated or treated with anti-Fas (30 or 60 min),
were fixed in 2.5% cacodylate-buffered (0.2 M, pH 7.2) glutaral-
dehyde for 20 min at RT and post-fixed in 1% OsO4 in
cacodylate buffer for 1 h at RT. Fixed specimens were dehydrated
through a graded series of ethanol solutions and embedded in
Agar 100 (Agar Aids, Cambridge, U.K.). Serial ultrathin sections
were collected on 200-mesh grids. Thin sections were then treated
with phosphate buffered saline (PBS) containing 1% (w/v) gelatin,
1% Bovine Serum Albumin, 5% Fetal Calf Serum and 0.05%
Tween 20 and then incubated with anti-CLIPR-59 polyclonal Ab
(kindly provided by Dr Franck Perez), overnight at 4uC. After
washing for 1 h at RT, sections were labeled with anti-rabbit IgG-
10 nm gold conjugate (1:10) for 1 h at RT and washed again.
Negative controls were incubated with the gold conjugate alone
and then counterstained with uranyl acetate and lead citrate.
Sections were observed with a Philips 208 electron microscope at
80 kV.
Morphometric analyses
Morphometric analyses were carried out by evaluating at least
200 cells at high magnification in order to detect gold particles
(20,0006) by transmission electron microscopy. Static cytometry
morphometry in double labeling experiments was carried out by
evaluating at least 200 cells at the same magnification (6306).
Analysis of CLIPR-59 expression in CEM cells by Western
Blot
CEM cells, untreated or treated with anti-CD95/Fas (250 ng/
ml for 30 min at 37uC) were lysed in lysis buffer (10 nM Tris-HCL
(pH 8.0), 150 mM NaCl, 1% Nonidet P-40, 1 mM PMSF,
10 mg/ml leupeptin). Total cell lysate from control and CD95/
Fas-treated cells were analyzed by Western blot. Samples were
probed with anti-CLIPR-59 polyclonal antibodies or with anti-b-
actin MoAb (Sigma Chemical Co, St. Louis, MO, USA) as a
control.
Immunofluorescence by intensified video microscopy
Control and treated cells (15, 30, 45 60, 75 min and 2 h) were
fixed with 4% paraformaldehyde in PBS for 30 min at room
temperature and then permeabilized with 0.5% Triton X-100 in
PBS for 5 min at room temperature, as previously reported [24].
After three washes in PBS, samples were incubated with GMR19
anti-GD3 MoAb (Seikagaku Corporation, Chuo-ku, Tokyo,
Japan) [25] or, alternatively, with R24 anti-GD3 (Matreya Inc.,
Pleasant Gap, PA) for 1 h at 4uC, followed by three washes in PBS
and addition (30 min at 4uC) of Alexa Fluor 594-conjugated anti-
mouse IgM or IgG (Molecular Probes, Leiden, The Netherlands).
The GMR19 anti-GD3 antibody is highly specific, as demon-
strated by thin layer chromatography immunostaining and
immunofluorescence analysis [25]. We further verified the
specificity of the antibody in CEM cells [10,13,14]. After washes,
cells were incubated with the anti-CLIPR-59 polyclonal Ab for 1 h
at 4uC, followed by addition (30 min at 4uC) of Alexa Fluor 488-
conjugated anti-rabbit IgG (Molecular Probes). Cells were finally
washed in PBS, and resuspended in 0.1 M Tris-HCl, pH 9.2,
containing 60% glycerol (v:v). and observed with a Nikon
Microphot fluorescence microscope. Images were captured by a
color chilled 3CCD camera (Hamamatsu, Japan) and analyzed by
the OPTILAB (Graftek, France) software.
Fluorescence resonance energy transfer by flow
cytometry
We applied FRET analysis by flow cytometry in order to study
the co-localization [26] of GD3/CLIPR-59 or GD3/b-Tubulin.
Briefly, cells, untreated or treated with anti-CD95/Fas (250 ng/ml
for different incubation times at 37uC) were fixed and permeabi-
lized as reported above [22]. In parallel experiments, cells were
pretreated with 100 mM 2-Bromopalmitate (Sigma Chem Co) [27]
for 3 h at 37uC to inhibit palmitoylation. After two washing in cold
PBS the cells were labeled with Abs tagged with donor (PE) or
acceptor (Cy5) dyes. GD3 staining was performed using unlabelled
mouse antibody (Seikagaku Corporation) and saturating amount
of PE-labeled anti-mouse IgM (Sigma). CLIPR-59 was revealed by
the anti-CLIPR-59 polyclonal Ab; tubulin was detected by anti-b-
Tubulin antibody (Abcam Ltd., Cambridge, UK), followed by
biotinylated anti-rabbit IgG and then saturating concentrations of
streptavidin-Cy5 (both from BD Pharmingen).
SiRNA CLIPR-59
CEM cells were cultured in a serum and antibiotic free medium
and transfected with Dharma FECT 4 reagent (Dharmacon,
Lafayette, CO), according to the manufacturer’s instructions,
using 100 nM Smart pool siRNA CLIPR-59. The transfection
efficiency was confirmed by using a Dharmacon’s positive
silencing control, siGLO laminin A/C siRNA.
After 72 h, the culture medium was replaced with fresh medium
and transfected again, as above, with 100 nM Smart pool siRNA
CLIPR-59. After further 48 h, the effect of transfection was
verified by Western blot and flow cytometry analyses with the
CLIPR-59 polyclonal Ab.
Preparation and labeling of isolated mitochondria
Control and CD95/Fas-treated cells were resuspended in
Homo-buffer (10 mM Hepes, pH 7.4; 1 mM ethylene glycol-
bis(-aminoethyl ether) N,N9,N0-tetraacetic acid (EGTA), 0.1 M
sucrose, 5% BSA, 1 mM phenylmethylsulfonyl fluoride (PMSF)
and complete protease inhibitor cocktail (Roche, Indianapolis, IN,
USA) for 10 min on ice. Cells were homogenized with a Teflon
homogenizer with B-type pestle [28] for 10 min at 4uC to remove
intact cells and nuclei. The supernatants were further centrifuged
at 10.0006ga t4 uC for 10 min to precipitate the heavy membrane
fractions (enriched in mitochondria). These fractions were then
purified by standard differential centrifugation. The mitochondrial
pellet obtained was fixed in paraformaldehyde for 1 h at 4uC and
then washed twice with PBS/0.5% BSA. Samples were divided
into equal parts, with only one part of each sample (positive
samples) incubated first with a saturating amount of anti-GD3
MoAb (Seikagaku Corporation), followed by appropriate second-
ary Ab, as reported above for the entire cells.
Cell-death assays
Quantification of apoptosis was performed by evaluating DNA
fragmentation in ethanol-fixed cells using propidium iodide (PI,
Sigma). Alternatively, apoptosis was also quantified by flow
cytometry after double staining using FITC-conjugated annexin
V/propidium iodide (PI) apoptosis detection kit (Eppendorf,
Milan, Italy), which allows discrimination between early apoptotic,
late apoptotic and necrotic cell.
GD3-CLIPR-59 Association
PLoS ONE | www.plosone.org 7 January 2010 | Volume 5 | Issue 1 | e8567Data analysis and statistics
For morphometric analyses statistical analyses were performed
by using student t test (Statview software for Macintosh computer).
For flow cytometry studies all samples were analyzed with a
FACScan cytometer (BD Biosciences, Heidelberg, Germany)
equipped with a 488 argon laser. At least 20,000 events were
acquired. Data were recorded and statistically analyzed by a
Macintosh computer using CellQuest Software. The expression
level of the analyzed proteins on intire cells or isolated
mitochondria was expressed as median fluorescence and the
statistical significance was calculated by using the parametric
Kolmogorov-Smirnov (K/S) test. For FRET studies samples were
recorded by a dual-laser FACScalibur cytometer (BD). Collected
data analysis was carried out by using ANOVA two-way test for
repeated samples by using Graphpad software. All data reported
in this paper were verified in at least three different experiments
and reported as mean6SD. Only p values of less than 0.01 were
considered significant.
Supporting Information
Figure S1 Time course evaluation of GD3-CLIPR-59 associa-
tion after CD95/Fas triggering by FRET efficiency calculation.
CEM cells, untreated or treated with anti-Fas (250 ng/ml for
different incubation times) were fixed and permeabilized as
reported in the text. After washings cells were pre-incubated with
10 mg/ml human IgG (Sigma) at room temperature for 10 min
and then incubated with saturating concentrations of the IgM PE-
conjugated and or anti biotinylated on ice for 30 min. After
washing, samples were divided into equal parts and only one part
(positive samples) incubated with a saturating amount of SA-Cy5
(0.6 mg/ml) for 30 min on ice. For determination of FRET
efficiency, changes in fluorescence intensities of donor plus
acceptor labeled cells were compared to the emission signal from
cells labeled with donor-only and acceptor-only fluorophores. All
data were corrected for background by subtracting the binding of
the isotype controls. Efficient energy transfer resulted in an
increased acceptor emission on cells stained with both donor and
acceptor dyes. The FRET efficiency (FE) was calculated according
to Riemann et al. (Biochem Biophys Res Commun 331: 1408–
1412, 2005), where A is the acceptor and D the donor, with the
formula: FE=(FL3DA2FL2DA/a2FL4DA/b)/FL3DA Where
a=FL2D/FL3D and b=FL4A/FL3A.
Found at: doi:10.1371/journal.pone.0008567.s001 (0.03 MB
PDF)
Figure S2 Statistical analyses (ANOVA) of FRET data in
Figure 4C. Data (A), tabular results (B) and narrative results (C) are
included.
Found at: doi:10.1371/journal.pone.0008567.s002 (1.10 MB
PDF)
Figure S3 Immunofluorescence analysis of GD3/mitochondria
association by R24 MoAb. Immunofluorescence analysis after
double staining of GD3 (red) and mitochondria (green) in control
and anti-CD95/Fas treated cells. Mitochondria were stained with
MitoTracker-Green and GD3 with anti-GD3 R24 MoAb,
followed by anti-mouse Alexa594.
Found at: doi:10.1371/journal.pone.0008567.s003 (18.08 MB
TIF)
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